Among patients with borderline personality disorder, symptom severity was associated with less stability and lower relative amplitude. Impulsivity and mood instability were each negatively correlated with interdaily stability and relative amplitude.
Exposure to childhood adversity is associated with borderline personality disorder.
Off-label use of oxcarbazepine and amantadine HCl appeared effective in maintaining improved symptomology in adolescent female patients with borderline personality disorder.
Delay discounting may be considered a transdiagnostic process across many psychiatric disorders, such as bipolar disorder and borderline personality disorder.
Paroxetine and naloxone displayed modest efficacy in controlling comorbid depersonalization and dissociative symptoms associated with posttraumatic stress disorder and borderline personality disorder.
Prevalence rates of major depressive disorder in patients with borderline personality disorder are higher than those reported by patients with other personality disorders; however, rates of remissions, recurrences, and new onsets were similar in both groups.
Individuals with borderline personality disorder may be at an elevated risk for premature death.
Investigators examined the effect of early trauma on impulsivity and the feature of impulsivity in bipolar disorder, borderline personality disorder, and ADHD.
The prevalence of borderline personality disorder is estimated to between 15% and 20% in inpatient settings.
The authors discouraged physicians from the prescription of lamotrigine, despite the “considerable pressure” that may be created by its recommendation in certain textbooks.
